Physiomics (PYC) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Dec 2016 07:00 AM
RNS
Payment for in-silico modelling of inhibitor
23 Nov 2016 07:00 AM
RNS
Posting of Financial Results and Notice of AGM
22 Nov 2016 07:00 AM
RNS
Provisional Award of Innovate UK Grant
27 Oct 2016 03:00 PM
RNS
Final Results for the year ended 30 June 2016
26 Oct 2016 07:00 AM
RNS
Presentation at Conference on Pharmacometrics
25 Oct 2016 07:00 AM
RNS
Directorate Change
28 Sep 2016 07:00 AM
RNS
Advisor Changes
21 Sep 2016 07:00 AM
RNS
Placing and Update on Acquisition
07 Sep 2016 12:19 PM
RNS
Result of GM
22 Aug 2016 07:00 AM
RNS
Notice of General Meeting
18 Aug 2016 07:00 AM
RNS
Signing of Share Purchase Agreement with BioMoti
16 Aug 2016 01:05 PM
RNS
Advisor Changes
16 May 2016 07:00 AM
RNS
Extensions for Virtual Tumour Project
03 May 2016 07:00 AM
RNS
Appointment of part-time Head of Finance
18 Apr 2016 09:02 AM
RNS
Physiomics Appoints New Chief Executive Officer
06 Apr 2016 10:15 AM
RNS
Virtual Tumour Developments Presentation at AACR
04 Apr 2016 12:12 PM
RNS
New Speciality Pharma Customer for new Indication
31 Mar 2016 07:01 AM
RNS
Interim Results Statement
31 Mar 2016 07:00 AM
RNS
Heads of Terms with BioMoti and Board Changes
22 Dec 2015 12:08 PM
RNS
Issue of Options
22 Dec 2015 07:00 AM
RNS
New Speciality Pharma Customer for New Indication
18 Dec 2015 10:57 AM
RNS
Placing
14 Dec 2015 10:29 AM
RNS
Result of General Meeting
04 Dec 2015 11:38 AM
RNS
Result of AGM
27 Nov 2015 04:15 PM
RNS
Notice of General Meeting
10 Nov 2015 07:00 AM
RNS
Final Results
06 Nov 2015 07:00 AM
RNS
Strategic Update
12 Oct 2015 07:00 AM
RNS
4th Large Pharma Customer for Virtual Tumour
09 Oct 2015 07:00 AM
RNS
Project extension with global pharma company
04 Aug 2015 07:01 AM
RNS
Prof. Mark Middleton appointed to Physiomics SAB
29 Apr 2015 04:27 PM
RNS
Holding(s) in Company
22 Apr 2015 07:00 AM
RNS
Virtual Tumour platform - AACR Annual Meeting 2015
26 Mar 2015 07:00 AM
RNS
Issue of Options
17 Mar 2015 07:00 AM
RNS
Half Yearly Report
12 Mar 2015 07:00 AM
RNS
Issue of Equity
06 Mar 2015 01:40 PM
RNS
Holding(s) in Company
04 Mar 2015 11:56 AM
RNS
Holding(s) in Company
03 Mar 2015 12:57 PM
RNS
First contract for clinical version of Virtu
20 Feb 2015 12:34 PM
RNS
Holding(s) in Company
02 Feb 2015 07:00 AM
RNS
Termination of Equity Swap Agreement
15 Dec 2014 01:08 PM
RNS
Result of AGM
12 Nov 2014 10:24 AM
RNS
Final Results
04 Nov 2014 07:00 AM
RNS
Disclosure of Large Pharma partner Merck & Co
27 Oct 2014 10:07 AM
RNS
Project extension with global pharma company
13 Oct 2014 04:43 PM
RNS
Holding(s) in Company
07 Oct 2014 09:35 AM
RNS
Cardiotox Platform Launch
29 Aug 2014 02:47 PM
RNS
Holding(s) in Company
14 Aug 2014 01:10 PM
RNS
New deal with global pharma
24 Jul 2014 12:59 PM
RNS
Issue of Equity
26 Jun 2014 07:57 AM
RNS
Holding(s) in Company

Physiomics plc is a UK-based company that uses mathematical models to help develop cancer treatments and personalized medicine. Services include Virtual Tumor modeling: A combination of proprietary and industry standard technologies that predict the effects of cancer treatments and drugs, Answering R&D questions: Helping clients de-risk drug development and build confidence in a molecule's clinical potential and Predicting therapeutic windows: Helping clients achieve a more quantitative understanding of new molecules.

PYC share price listed at 231p in 2004.

UK 100

Latest directors dealings